Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide Source: International Congress 2018 – Basic pharmacology Year: 2018
MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018
Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007
Dose dependent effect of thrombomodulin in a murine model of allergen-induced asthma Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Late-breaking abstract: Inhaled calcium based dry powder inhibits rhinovirus-induced inflammation and exacerbation in a mouse model of allergic airway inflammation Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011
Treatment with gp120 reduces AHR and airway inflammation in a humanized mouse model of asthma bronchiale Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001
Caspase-1 deficiency reduces eosinophilia and interleukin-33 in an asthma exacerbation model Source: ERJ Open Res, 3 (4) 00047-2017; 10.1183/23120541.00047-2017 Year: 2017
Estrogen prevents airway inflammation and hyperresponsiveness in a murine model of acute allergic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 360s Year: 2007
Roflumilast inhibits chemokine release in animal models of COPD and asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Influence of CpG-oligodeoxynucleotides and dexamethasone on remodeling and expression of MMP-9 in murine model of chronic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Pentoxifylline inhibits the neutrophil alveolitis in a murine ARDS model Source: Eur Respir J 2001; 18: Suppl. 33, 238s Year: 2001
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Estrogen prevents airway hyperresponsiveness in a murine model of allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006
Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005
Effect of roflumilast on neutrophilic asthma model Source: International Congress 2017 – Animal models of asthma and allergies Year: 2017
Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012